scholarly article | Q13442814 |
P356 | DOI | 10.1002/MRM.10080 |
P698 | PubMed publication ID | 11870848 |
P50 | author | David Buckley | Q42855553 |
P2093 | author name string | David L. Buckley | |
P2860 | cites work | Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data | Q30578197 |
Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI Group | Q30591279 | ||
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. | Q33744660 | ||
Modeling tracer kinetics in dynamic Gd-DTPA MR imaging | Q41352795 | ||
Tracer-kinetic models for measuring cerebral blood flow using externally detected radiotracers | Q48224800 | ||
An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation | Q48331032 | ||
Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts | Q48797418 | ||
Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors | Q48884217 | ||
Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. | Q52074468 | ||
Noninvasive assessment of the functional neovasculature in 9L-glioma growing in rat brain by dynamic 1H magnetic resonance imaging of gadolinium uptake. | Q52539380 | ||
Temporal sampling requirements for the tracer kinetics modeling of breast disease. | Q52906866 | ||
Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours | Q56589759 | ||
Microvessel density in invasive breast cancer assessed by dynamic gd-dtpa enhanced MRI | Q56589987 | ||
P433 | issue | 3 | |
P921 | main subject | magnetic resonance imaging | Q161238 |
P304 | page(s) | 601-606 | |
P577 | publication date | 2002-03-01 | |
P1433 | published in | Magnetic Resonance in Medicine | Q6731496 |
P1476 | title | Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI | |
P478 | volume | 47 |
Q51682947 | A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas. |
Q44337183 | A unified impulse response model for DCE-MRI. |
Q33997699 | Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study. |
Q45840193 | Analysis of parametric histogram from dynamic contrast-enhanced MRI: application in evaluating brain tumor response to radiotherapy |
Q36417718 | Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings |
Q36750627 | Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI. |
Q48226842 | Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI. |
Q92875613 | Biopsy Confirmed Glioma Recurrence Predicted by Multi-Modal Neuroimaging Metrics |
Q39387171 | Blind estimation of the arterial input function in dynamic contrast-enhanced MRI using purity maximization |
Q35015049 | Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model? |
Q35946168 | Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI |
Q55471802 | Comparative study of methods for determining vascular permeability and blood volume in human gliomas. |
Q36120153 | Comparison of Cerebral Blood Volume and Plasma Volume in Untreated Intracranial Tumors |
Q51965252 | Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats rhabdomyosarcoma. |
Q45860260 | Computer assisted analysis of MR-mammography reveals association between contrast enhancement and occurrence of distant metastasis |
Q36103551 | Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas |
Q35170356 | Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. |
Q38074638 | Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies |
Q33507482 | Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging |
Q33552489 | Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy |
Q33510695 | Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples |
Q36258939 | Dynamic Contrast-Enhanced MRI in the Study of Brain Tumors. Comparison Between the Extended Tofts-Kety Model and a Phenomenological Universalities (PUN) Algorithm |
Q37684706 | Dynamic Contrast-Enhanced Magnetic Resonance Enterography and Dynamic Contrast-Enhanced Ultrasonography in Crohn's Disease: An Observational Comparison Study. |
Q41000474 | Dynamic Contrast-Enhanced Perfusion MRI of High Grade Brain Gliomas Obtained with Arterial or Venous Waveform Input Function |
Q38725827 | Dynamic contrast-enhanced MRI for oncology drug development |
Q37983692 | Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies |
Q51065208 | Dynamic contrast-enhanced MRI in mice: an investigation of model parameter uncertainties. |
Q30456007 | ESR statement on the stepwise development of imaging biomarkers |
Q51703095 | Estimation of tissue perfusion by dynamic contrast-enhanced imaging: simulation-based evaluation of the steepest slope method. |
Q51593516 | Extended graphical model for analysis of dynamic contrast-enhanced MRI. |
Q34550986 | Fast, reproducible measurement of the vascular input function in mice using constrained reconstruction and cardiac sampling. |
Q35116981 | Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging |
Q45981337 | Glucosamine sulfate effect on the degenerated patellar cartilage: preliminary findings by pharmacokinetic magnetic resonance modeling. |
Q45968202 | High temporal resolution 3D gadolinium-enhanced dynamic MR imaging of renal tumors with pharmacokinetic modeling: preliminary observations. |
Q35625666 | High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI. |
Q34203930 | Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours |
Q36464131 | Imaging heterogeneity of peptide delivery and binding in solid tumors using SPECT imaging and MRI |
Q51573923 | Imaging microvascular structure with contrast enhanced MRI. |
Q31144032 | Imaging of angiogenesis: from microscope to clinic |
Q89427753 | Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancer |
Q30579313 | Impact of transvascular and cellular-interstitial water exchange on dynamic contrast-enhanced magnetic resonance imaging estimates of blood to tissue transfer constant and blood plasma volume. |
Q38902139 | In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats. |
Q31153802 | Incorporating a vascular term into a reference region model for the analysis of DCE-MRI data: a simulation study |
Q51657981 | Kinetic Models for Cancer Imaging |
Q37270567 | MR imaging of the prostate in clinical practice |
Q35905005 | MRI for assessing antivascular cancer treatments |
Q92672901 | Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists |
Q33436273 | Magnetic resonance imaging as a biomarker in renal cell carcinoma |
Q37436294 | Magnetic resonance imaging defines cervicovaginal anatomy, cancer, and VEGF trap antiangiogenic efficacy in estrogen-treated K14-HPV16 transgenic mice. |
Q30479156 | Magnetic resonance perfusion imaging in neuro-oncology. |
Q30442598 | Markers of cochlear inflammation using MRI. |
Q33711249 | Measurement of blood-brain barrier permeability with t1-weighted dynamic contrast-enhanced MRI in brain tumors: a comparative study with two different algorithms. |
Q45343210 | Modeling DCE-MRI at low temporal resolution: a case study on rheumatoid arthritis |
Q38282639 | Models and methods for analyzing DCE-MRI: a review. |
Q34203974 | Multicentre imaging measurements for oncology and in the brain. |
Q34538659 | Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer |
Q38774733 | Multiphasic contrast injection for improved precision of parameter estimates in functional CT. |
Q37876335 | New acquisition techniques: fields of application |
Q64067937 | Noninvasive monitoring of blood flow using a single magnetic microsphere |
Q46265644 | On the scope and interpretation of the Tofts models for DCE-MRI. |
Q38860709 | Optimization of arterial spin labeling MRI for quantitative tumor perfusion in a mouse xenograft model. |
Q43464254 | Optimized pharmacokinetic modeling for the detection of perfusion differences in skeletal muscle with DCE-MRI: effect of contrast agent size |
Q57298860 | Parameterized level-set based pharmacokinetic fluorescence optical tomography using the regularized Gauss-Newton filter |
Q47322697 | Performance of Ultrafast DCE-MRI for Diagnosis of Prostate Cancer. |
Q37749568 | Perfusion MRI in the early clinical development of antivascular drugs: decorations or decision making tools? |
Q27012911 | Perfusion magnetic resonance imaging: a comprehensive update on principles and techniques |
Q33703176 | Pharmacokinetic analysis of tissue microcirculation using nested models: multimodel inference and parameter identifiability |
Q49076621 | Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI. |
Q51411292 | Quantification of pulmonary microcirculation by dynamic contrast-enhanced magnetic resonance imaging: comparison of four regularization methods. |
Q33911988 | Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma |
Q31138977 | Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer |
Q92489166 | Reliability of dynamic contrast-enhanced magnetic resonance imaging data in primary brain tumours: a comparison of Tofts and shutter speed models |
Q42917550 | Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population |
Q34367593 | Review of treatment assessment using DCE-MRI in breast cancer radiation therapy |
Q35110740 | Semi-quantitative parameter analysis of DCE-MRI revisited: monte-carlo simulation, clinical comparisons, and clinical validation of measurement errors in patients with type 2 neurofibromatosis. |
Q35215149 | Simulation study of the effect of golden-angle KWIC with generalized kinetic model analysis on diagnostic accuracy for lesion discrimination |
Q46863259 | Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI. |
Q38764089 | Simultaneous measurement of T1 /B1 and pharmacokinetic model parameters using active contrast encoding (ACE)-MRI. |
Q37049919 | Statistical Learning Algorithm for in situ and invasive breast carcinoma segmentation |
Q30775286 | Steady-state and dynamic contrast MR imaging of human prostate cancer xenograft tumors: a comparative study |
Q42123025 | Suppression of vascular enhancement artifacts through the use of a multiband, selectively spoiled radiofrequency excitation pulse |
Q33660443 | Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model |
Q33534774 | The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI data |
Q34635573 | The use of dynamic tracer concentration in veins for quantitative DCE-MRI kinetic analysis in head and neck. |
Q30873526 | The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data. |
Q31136105 | Theoretical basis of hemodynamic MR imaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability |
Q33800926 | Three-dimensional dynamic contrast enhanced imaging of the carotid artery with direct arterial input function measurement. |
Q42606877 | Tissue-specific compartmental analysis for dynamic contrast-enhanced MR imaging of complex tumors. |
Q37760857 | Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements |
Q36421776 | Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments |
Q37995577 | Tumor response assessments with diffusion and perfusion MRI. |
Q47104951 | TumourMetrics: a comprehensive clinical solution for the standardization of DCE-MRI analysis in research and routine use. |
Q33664381 | Ultrafast 3D spin-echo acquisition improves Gadolinium-enhanced MRI signal contrast enhancement |
Q33951156 | Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences |
Q45401985 | Uncertainty estimation in dynamic contrast-enhanced MRI. |
Q30665072 | Uncertainty in MR tracer kinetic parameters and water exchange rates estimated from T1-weighted dynamic contrast enhanced MRI |
Q36264886 | Validation of Blood Volume Fraction Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscle. |
Q46640157 | Validity of perfusion parameters obtained using the modified Tofts model: a simulation study |
Q80212243 | [Magnetic resonance imaging of angiogenesis in tumors] |
Search more.